Cuando la mama y la axila no opinan lo mismo: la discordancia tras neoadyuvancia en TNBC

Un estudio retrospectivo analizó 651 pacientes con cáncer de mama triple negativo (TNBC) que recibieron quimioterapia neoadyuvante (NACT) y posterior cirugía.

Un estudio retrospectivo analizó 651 pacientes con cáncer de mama triple negativo (TNBC) que recibieron quimioterapia neoadyuvante (NACT) y posterior cirugía.
Title: KRAS G12C responds better to immunotherapy: the KRAS subtype matters in NSCLC (real-world) Type: B (clinical / real-world) Tags: KRAS, NSCLC, immunotherapy, biomarkers, real-world PMID: 42607379 DOI: 10.1016/j.lungcan.2026.109560 Jou…

Title: Synthetic medical data: the FDA proposes 7 criteria to use them without fooling ourselves Type: C (AI / data governance / LOPD) Tags: synthetic data, medical AI, FDA, privacy, evaluation, mammography PMID: 42602824 DOI: 10.1093/bjrai…

Title: RIBOLARIS: ribociclib in neoadjuvant and adjuvant settings for high-risk HR+ breast cancer — a paradigm shift Type: B (clinical / real-world) Tags: ribociclib, CDK4/6, HR+ breast cancer, neoadjuvant, adjuvant, RIBOLARIS PMID: 4260222…
⚖️ Transparency notice: this article was written with AI assistance and reviewed by the author, a medical oncologist.
⚖️ Transparency notice: this article was written with AI assistance and reviewed by the author, a medical oncologist.
Title: AI in mammography: does not prolong reading time and detects more cancers — prospective alternating months study Type: A (AI medical imaging / breast) Tags: AI mammography, detection, screening, radiology, MARTE PMID: 42593499 DOI: 1…
Title: Menopause does not modulate the benefit of CDK4/6 inhibitors in adjuvant setting: phase III meta-analysis Type: B (clinical / real-world) Tags: CDK4/6, HR+ breast cancer, adjuvant, menopause, ribociclib, abemaciclib PMID: 42593586 DO…
⚖️ Transparency notice: this article was written with AI assistance and reviewed by the author, a medical oncologist.
Exercise improves cognitive function in cancer patients: network meta-analysis of 27 RCTs and 2,809 patients shows consistent short- and long-term benefit.